Finance

Lists
Outlook: 92.3% bullish·0.0% bearish
Go to analysis
AXGN:NASDAQ
AxoGen, Inc Common Stock
$49.85
+0.97%
(+0.48) 1D
$49.85
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AXGN...
Open
$49.46
High
$50.54
Low
$49.04
Mkt. cap
2.98B
Avg. vol.
1.74M
Volume
0.00
52-wk high
$52.91
52-wk low
$21.94
EPS
-$0.68
Beta
1.17
Shares outstanding
59.73M
No. of employees
622
Open
$49.46
High
$50.54
Low
$49.04
Mkt. cap
2.98B
Avg. vol.
1.74M
Volume
0.00
52-wk high
$52.91
52-wk low
$21.94
EPS
-$0.68
Beta
1.17
Shares outstanding
59.73M
No. of employees
622
News stories
From web sources and news partners
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Florida, United States
SectorMedical device
Analyst ratings
Based on 11 analysts giving stock ratings to AXGN in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for AXGN in the last 3 months.
Highest
Current $49.85
$65.00 (+30.39%)
Average
$58.00 (+16.35%)
Lowest
$48.00 (-3.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ravi Misra
Truist Financial
Buy
Maintained
$60.00
+20.4%
10/29/2026
Travis Steed
Bank of America Securities
Buy
Maintained
$62.00
+24.4%
10/29/2026
Frank Takkinen
Lake Street
Buy
Maintained
$58.00
+16.3%
10/29/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
$56.00
+12.3%
10/29/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$65.00
+30.4%
10/29/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
$60.00
+20.4%
10/29/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$56.00
+12.3%
10/29/2026
Christopher Pasquale
Barclays
Buy
Maintained
$60.00
+20.4%
10/29/2026
Michael Sarcone
Jefferies
Buy
Reiterated
$60.00
+20.4%
10/28/2026
Unknown Analyst
Barclays
Buy
Initiated
$55.00
+10.3%
10/06/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
$48.00
-3.7%
10/02/2026
Jayson Bedford
Raymond James
Buy
Maintained
$53.00
+6.3%
09/25/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$48.00
-3.7%
09/11/2026
David Turkaly
Citizens JMP
Buy
Maintained
$55.00
+10.3%
07/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
59.90M
61.46M
69.73M
75.83M
Cost of goods sold
15.50M
15.27M
19.06M
19.10M
Cost of revenue
15.50M
15.27M
19.06M
19.10M
Research and development expenses
12.38M
7.52M
8.59M
8.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.80M
41.50M
44.24M
46.83M
Operating expense
54.18M
49.02M
52.83M
55.78M
Total operating expenses
69.68M
64.29M
71.89M
74.88M
Operating income
-9.77M
-2.83M
-2.16M
955.00K
Other non operating income
-2.02M
23.00K
-145.00K
-51.00K
EBT including unusual items
-13.16M
-19.58M
-1.52M
2.33M
EBT excluding unusual items
-13.16M
-2.74M
-1.52M
2.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.16M
-19.58M
-1.52M
2.33M
Net profit margin
-21.96%
-31.87%
-2.17%
3.08%
Earnings per share
0.07
0.07
0.12
0.21
Interest and investment income
352.00K
768.00K
786.00K
1.43M
Interest expense
-1.72M
-694.00K
-1.00K
-1.00K
Net interest expenses
-1.37M
74.00K
785.00K
1.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.04M
-1.13M
-438.00K
2.65M
Gain or loss from assets sale
-
-
7.00K
19.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps